Daniel George Wildman - 08 Nov 2022 Form 3 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
08 Nov 2022
Net transactions value
$0
Form type
3
Filing time
09 Nov 2022, 16:57:34 UTC
Next filing
08 Sep 2023

No securities are beneficially owned.